Bioactive compounds and methods of uses thereof

Details for Australian Patent Application No. 2005323436 (hide)

Owner Regents of the University of Minnesota Rutgers, The State University of New Jersey Wellgen, Inc.

Inventors Dong, Zigang; Bai, Naisheng; Ho, ChiTang; Dushenkov, Slavik; Bode, Anne

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005323436

PCT Pub. Number WO2006/073457

Priority 60/567,340 30.04.04 US

Filing date 2 May 2005

Wipo publication date 13 July 2006

International Classifications

A61K 31/353 (2006.01)

C07D 305/14 (2006.01) Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2006/073457 Priority application(s): WO2006/073457

25 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005323437-Oligonucleotides comprising a C5-modified pyrimidine

2005323435-Anti-coronavirus compounds